EcoDrugPlus

Ensembl ID : ENSACIG00000000170
Gene Symbol: RPL23
1 Cross references
231 Possible Orthologues:

Ensembl ID : ENSACIG00000002092
Gene Symbol: -
Cross references: -
238 Possible Orthologues:

Ensembl ID : ENSACIG00000023922
Gene Symbol: -
1 Cross references
233 Possible Orthologues:

Ensembl ID : ENSACIG00000023805
Gene Symbol: RPL34
1 Cross references
364 Possible Orthologues:

Ensembl ID : ENSACIG00000022262
Gene Symbol: RPL24
1 Cross references
318 Possible Orthologues:

Ensembl ID : ENSACIG00000020232
Gene Symbol: RPL8
1 Cross references
277 Possible Orthologues:

Ensembl ID : ENSACIG00000019183
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSACIG00000021328
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSACIG00000010435
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSACIG00000018055
Gene Symbol: RPS15A
1 Cross references
563 Possible Orthologues:

Ensembl ID : ENSACIG00000000269
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSACIG00000016765
Gene Symbol: -
Cross references: -
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).